Clinical Trial Update: Janus Kinase Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial from Stanford is evaluating whether a Janus kinase (JAK) inhibitor can prevent ventilator-induced diaphragm dysfunction and the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-induced Diaphragmatic Dysfunction

Drugs mentioned

• Unspecified Janus kinase (JAK) inhibitor (Janus kinase (JAK) inhibitor)

Snippet

Sponsor: Stanford University | Conditions: Diaphragm Injury | Phase 2 | Status: RECRUITING